These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2873602)

  • 21. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
    Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
    Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardized assessment of psychopathology by relatives of mentally disordered patients. Preliminary results of using the positive and negative syndrome scale to compare schizophrenic and affective disorders.
    Nitsche I; Kallert TW
    Psychopathology; 2007; 40(4):242-53. PubMed ID: 17440287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new rating scale for negative symptoms: the Motor-Affective-Social Scale.
    Trémeau F; Goggin M; Antonius D; Czobor P; Hill V; Citrome L
    Psychiatry Res; 2008 Sep; 160(3):346-55. PubMed ID: 18722021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hopelessness in schizophrenia: the impact of symptoms and beliefs about illness.
    White RG; McCleery M; Gumley AI; Mulholland C
    J Nerv Ment Dis; 2007 Dec; 195(12):968-75. PubMed ID: 18091189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
    Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
    Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical assessment of schizophrenic syndrome (CASS): validity evaluation of the new diagnostic tool].
    Wciórka J; Anczewska M; Bembenek A; Gołebiewska M; Hochlewicz A; Nurowska K; Schaeffer E; Skowrońska J; Stanikowska I; Tarczyńska K
    Psychiatr Pol; 2000; 34(2):203-21. PubMed ID: 10974936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.
    Harvey PD; Serper MR; White L; Parrella MJ; McGurk SR; Moriarty PJ; Bowie C; Vadhan N; Friedman J; Davis KL
    Compr Psychiatry; 2001; 42(4):306-13. PubMed ID: 11458305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of environmental deprivation on negative symptoms of schizophrenia: a nationwide survey in Japan's psychiatric hospitals.
    Oshima I; Mino Y; Inomata Y
    Psychiatry Res; 2005 Sep; 136(2-3):163-71. PubMed ID: 16125788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients].
    Peralta Martín V; Cuesta Zorita MJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994; 22(4):171-7. PubMed ID: 7810373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mortality among chronic schizophrenic patients: a prospective 14-year follow-up study of 150 schizophrenic patients].
    Loas G; Azi A; Noisette C; Yon V
    Encephale; 2008 Jan; 34(1):54-60. PubMed ID: 18514151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining and measuring negative symptoms of schizophrenia in clinical trials.
    Marder SR; Kirkpatrick B
    Eur Neuropsychopharmacol; 2014 May; 24(5):737-43. PubMed ID: 24275698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can we combine symptom scales for collaborative research projects?
    Lyne JP; Kinsella A; O'Donoghue B
    J Psychiatr Res; 2012 Feb; 46(2):233-8. PubMed ID: 22056401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tools to assess negative symptoms in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2013 Jun; 74(6):e12. PubMed ID: 23842020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between the Brief Psychiatric Rating Scale and the Scale for the Assessment of Negative Symptoms: a study of their correlation and redundancy.
    Czobor P; Bitter I; Volavka J
    Psychiatry Res; 1991 Feb; 36(2):129-39. PubMed ID: 2017528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between feasibility of discharge, clinical state, and patient attitude among inpatients with schizophrenia in Japan.
    Mino Y; Oshima I; Shimodera S
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):344-9. PubMed ID: 19566766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The BPRS in assessing symptom correlates of cerebral ventricular enlargement in acute and chronic schizophrenia.
    Bishop RJ; Golden CJ; MacInnes WD; Chu CC; Ruedrich SL; Wilson J
    Psychiatry Res; 1983 Jul; 9(3):225-31. PubMed ID: 6604928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive disturbances in chronic schizophrenia: formal thought disorder and basic symptoms.
    Simhandl C; Dietzel M; Lesch OM; Musalek M; Strobl R
    Psychopathology; 1986; 19(4):206-12. PubMed ID: 2882543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Negative Symptom Rating Scale.
    Iager AC; Kirch DG; Wyatt RJ
    Psychiatry Res; 1985 Sep; 16(1):27-36. PubMed ID: 3864173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.